Ascentage Pharma Group International
AAPG | NASDAQ
$15.86
+$0.80 (+5.31%)
At close: Sep 21, 2026, 4:00 PM ET
$15.82
-$0.04 (-0.25%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q4 2025 Dec 30, 2025 | Q2 2025 Jun 29, 2025 | Q4 2024 Dec 30, 2024 | Q2 2024 Jun 29, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q2 2022 Jun 29, 2022 | Q4 2021 Dec 30, 2021 | Q2 2021 Jun 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 1.9B | 2.47B | 1.66B | 1.24B | 1.1B | 1.07B | 1.58B | 1.48B | 1.7B | 1.71B | 1.1B |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 428.7M |
Long-Term Investments | 40.02M | 37.05M | 37.34M | 33.86M | 33.2M | 18.95M | 18.66M | 18.53M | 21.1M | n/a | n/a |
Other Long-Term Assets | 26.37M | 30.74M | 99.06M | 59M | 19.3M | 10.05M | 400.73M | 361.93M | 64.36M | 63.73M | 105.05M |
Receivables | 156.45M | 253.1M | 78.36M | 99.07M | 852.81M | 163.54M | 174.22M | 61.49M | 161.51M | 54.13M | 66.34M |
Inventory | 64.32M | 28.64M | 8.59M | 6.6M | 10.72M | 16.17M | 5.02M | 9.45M | 5.25M | 3.93M | n/a |
Other Current Assets | 177.05M | 192.65M | 160.31M | 24.63M | n/a | 24.54M | n/a | 16.6M | -80.83M | 59.26M | -56M |
Total Current Assets | 2.29B | 2.95B | 1.91B | 1.47B | 1.96B | 1.34B | 1.76B | 1.64B | 1.87B | 1.89B | 1.6B |
Property-Plant & Equipment | 800.72M | 829.59M | 871.96M | 905.86M | 931.18M | 957.23M | 633.06M | 650.03M | 968.46M | 854.3M | 616.64M |
Goodwill & Intangibles | 62.28M | 90.69M | 95.69M | 100.69M | 104.47M | 110.14M | 104.8M | 109M | 115.53M | 85.11M | 88.47M |
Total Long-Term Assets | 947.77M | 1.02B | 1.14B | 1.14B | 1.14B | 1.16B | 1.16B | 1.19B | 1.17B | 1.05B | 810.15M |
Total Assets | 3.24B | 3.97B | 3.05B | 2.62B | 3.11B | 2.5B | 2.92B | 2.83B | 3.03B | 2.94B | 2.41B |
Account Payables | 106.95M | 106.81M | 118.68M | 91.97M | 83.08M | 72.45M | 47.72M | 95.56M | 85.73M | 70.86M | 28.4M |
Deferred Revenue | 69.56M | 37.51M | n/a | 54.09M | n/a | 38.41M | n/a | 24.35M | n/a | n/a | n/a |
Short-Term Debt | 1.48B | 1.22B | 822.61M | 769.62M | 720.1M | 606.65M | 396M | 510.31M | 298.93M | 39.8M | 23.95M |
Other Current Liabilities | 232.01M | 276.84M | 286.84M | n/a | 37.49M | n/a | 24.35M | 2.82M | 30M | 58.73M | 25K |
Total Current Liabilities | 1.88B | 1.64B | 1.24B | 1.17B | 1.07B | 934.17M | 642.88M | 881.15M | 612.3M | 361.11M | 193.79M |
Long-Term Debt | 605.56M | 742.8M | 867.11M | 868.64M | 959.14M | 1.17B | 1.26B | 1.27B | 1.24B | 1.03B | 622.54M |
Other Long-Term Liabilities | 7.16M | 12.04M | 248.55M | 6.27M | 18.8M | 18.3M | 185.31M | 35.33M | 52.63M | 52.34M | 75.97M |
Total Long-Term Liabilities | 791.64M | 986.62M | 1.13B | 1.18B | 1.27B | 1.5B | 1.68B | 1.54B | 1.55B | 1.34B | 764.52M |
Total Liabilities | 2.68B | 2.63B | 2.37B | 2.34B | 2.33B | 2.43B | 2.32B | 2.42B | 2.16B | 1.71B | 958.31M |
Total Debt | 2.1B | 1.98B | 1.72B | 1.67B | 1.7B | 1.8B | 1.68B | 1.79B | 1.56B | 1.08B | 667.41M |
Book Value | 566.03M | 1.34B | 675.91M | 274.16M | 776.44M | 70.63M | 600.18M | 408.66M | 876.85M | 1.23B | 1.45B |
Book Value Per Share | 6.07 | 14.42 | 7.91 | 3.51 | 10.49 | 0.97 | 34.02 | 24.80 | 53.21 | 77.59 | 91.11 |
Common Stock | 256.09K | 256.16K | 239K | 214K | 214K | 197K | 196K | 180K | 179K | 178K | 172K |
Retained Earnings | -7.83B | n/a | -6.36B | -5.77B | -5.2B | -5.37B | -4.84B | -4.44B | -3.96B | -3.56B | n/a |
Comprehensive Income | -524.37M | 1.33B | -516.07M | -510.59M | -501.79M | -504.46M | n/a | -518.51M | -517.93M | n/a | n/a |
Shareholders Equity | 556.58M | 1.33B | 666M | 264.19M | 766.4M | 60.42M | 589.89M | 408.66M | 876.85M | 1.23B | 1.45B |
Total Investments | 40.02M | 37.05M | 37.34M | 33.86M | 33.2M | 18.95M | 18.66M | 18.53M | 21.1M | n/a | 428.7M |
Add to Watchlist
Select watchlists to add or remove AAPG